Millions are in search of improved ways to manage type 2 diabetes. Medication and insulin products are continually being brought to the market. However, the continuous flow of new medication is not the ‘new’ treatment diabetes patients are interested in to facilitate a natural path to reverse diabetes.
Dementia and Alzheimer’s Disease have been at the forefront of many health discussions. It is a fear that many of our aging population believe there is no answer. While much research is still needed, there is a term, ‘Type 3 Diabetes’ that may provide some insight into one area of Alzheimer’s Disease.
Over 34.2 million people in the U.S. have diabetes which is the 7th leading cause of death. More than 5 million Americans have Alzheimer’s which is the 6th leading cause of death.
I promised an update on the Metformin recall. The FDA has been in contact with five companies to recommend that they voluntarily recall Extended Release metformin due to unacceptable levels of a possible carcinogen called NDMA.
The companies are Apotex, Amneal, Marksans, Lupin, Teva/Actavis.
Symptoms are signs. Do you pay attention or ignore them?
Symptom, a physical or mental feature which is regarded as indicating a condition of disease, particularly such a feature that is apparent to the patient. Have you noticed any of the following symptoms?
• Fatigue, frequently tired or have that foggy feeling
• Difficulty maintaining a healthy weight
• Broken sleep having to urinate too often
• Vision changes such as floaters, blurred vision, dark or empty spots
On May 28, 2020, the FDA announced a recall on Metformin and earlier on some ranitidine medicines, better known as Zantac to contain a nitrosamine impurity called NDMA, which is classified as a probable human carcinogen.